Format

Send to

Choose Destination
Crit Care. 2016 Nov 28;20(1):387.

The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology.

Author information

1
Critical Care Research Group, University of Queensland, Brisbane, Australia. j.millar@doctors.org.uk.
2
Critical Care Research Group, The Prince Charles Hospital, Rode Road, Chermside, Queensland, 4032, Australia. j.millar@doctors.org.uk.
3
Critical Care Research Group, University of Queensland, Brisbane, Australia.
4
Wellcome-Wolfson Centre for Experimental Medicine, Queen's University Belfast, Belfast, UK.

Abstract

Extracorporeal membrane oxygenation (ECMO) is a technology capable of providing short-term mechanical support to the heart, lungs or both. Over the last decade, the number of centres offering ECMO has grown rapidly. At the same time, the indications for its use have also been broadened. In part, this trend has been supported by advances in circuit design and in cannulation techniques. Despite the widespread adoption of extracorporeal life support techniques, the use of ECMO remains associated with significant morbidity and mortality. A complication witnessed during ECMO is the inflammatory response to extracorporeal circulation. This reaction shares similarities with the systemic inflammatory response syndrome (SIRS) and has been well-documented in relation to cardiopulmonary bypass. The exposure of a patient's blood to the non-endothelialised surface of the ECMO circuit results in the widespread activation of the innate immune system; if unchecked this may result in inflammation and organ injury. Here, we review the pathophysiology of the inflammatory response to ECMO, highlighting the complex interactions between arms of the innate immune response, the endothelium and coagulation. An understanding of the processes involved may guide the design of therapies and strategies aimed at ameliorating inflammation during ECMO. Likewise, an appreciation of the potentially deleterious inflammatory effects of ECMO may assist those weighing the risks and benefits of therapy.

KEYWORDS:

Coagulation; ECMO; Extracorporeal membrane oxygenation; Inflammation; SIRS

PMID:
27890016
PMCID:
PMC5125043
DOI:
10.1186/s13054-016-1570-4
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center